Quantitative analysis of retroviral and lentiviral gene transfer to murine embryonic stem cells

被引:4
作者
Chilton, Jamie M. [2 ]
Le Doux, Joseph M. [1 ,2 ]
机构
[1] Georgia Tech & Emory Univ, Wallace H Coulter Dept Biomed Engn, Petit Inst Bioengn & Biosci, IBB, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA
关键词
Gene therapy; Lentivirus; Retrovirus; Gene expression; Transduction efficiency; Embryonic stem cells;
D O I
10.1016/j.jbiotec.2008.07.1996
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The effectiveness of retrovirus or lentivirus transduction of embryonic stem (ES) cells is often limited because transgene expression is silenced or variegated. We wondered if other steps of transduction, in addition to gene expression, were restricted in ES cells. We quantitatively compared (1) the amount of virus binding, (2) the number of integrated transgenes, and (3) the resulting level of gene expression. We found that three- to fourfold fewer retroviruses and lentiviruses bound to R1 mES cells than to NIH 3T3 cells, suggesting that both types of viruses bind less efficiently to mES cells. Retroviruses and lentiviruses differed in the efficiency with which they completed post-binding steps of transduction. In R1 mES cells, we detected 3-fold fewer integrated retrovirus transgenes and 11-fold lower expression levels than in NIH 3T3 cells, which suggests that the primary limitation to retrovirus transduction may be low levels of transgene expression. In contrast, we detected 10-fold fewer integrated lentivirus transgenes and 8-fold lower expression levels in R1 mES cells than in NIH 3T3 cells, which suggests that lentivirus transduction may be limited by inefficient intracellular post-binding steps of transduction. The implications of our findings for developing improved viral vectors for transducing mES cells are discussed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 36 条
  • [1] Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection (vol 74, pg 1258, 2000)
    Andreadis, S
    Lavery, T
    Davis, HE
    Le Doux, JM
    Yarmush, ML
    Morgan, JR
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (07) : 3431 - 3439
  • [2] Andreadis Stelios T, 2002, Methods Mol Med, V69, P161
  • [3] Positional cloning of the mouse retrovirus restriction gene Fv1
    Best, S
    LeTissier, P
    Towers, G
    Stoye, JP
    [J]. NATURE, 1996, 382 (6594) : 826 - 829
  • [4] Identification of the regions of Fv1 necessary for murine leukemia virus restriction
    Bishop, KN
    Bock, M
    Towers, G
    Stoye, JP
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (11) : 5182 - 5188
  • [5] Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors
    Case, SS
    Price, MA
    Jordan, CT
    Yu, XJ
    Wang, LJ
    Bauer, G
    Haas, DL
    Xu, DK
    Stripecke, R
    Naldini, L
    Kohn, DB
    Crooks, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 2988 - 2993
  • [6] Trim5α accelerates degradation of cytosolic capsid associated with productive HIV-1 entry
    Chatterji, Udayan
    Bobardt, Michael D.
    Gaskill, Peter
    Sheeter, Dennis
    Fox, Howard
    Gallay, Philippe A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) : 37025 - 37033
  • [7] CHILTON JM, 2008, BIOTECHNOL APPL 0211
  • [8] HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM
    COSSET, FL
    TAKEUCHI, Y
    BATTINI, JL
    WEISS, RA
    COLLINS, MKL
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (12) : 7430 - 7436
  • [9] Silencing and variegation of gammaretrovirus and lentivirus vectors
    Ellis, J
    [J]. HUMAN GENE THERAPY, 2005, 16 (11) : 1241 - 1246
  • [10] Retrovirus silencing and vector design: Relevance to normal and cancer stem cells?
    Ellis, J
    Yao, SY
    [J]. CURRENT GENE THERAPY, 2005, 5 (04) : 367 - 373